Citadel Advisors’s Anixa Biosciences ANIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $234K | Buy |
+70,938
| New | +$234K | ﹤0.01% | 4865 |
|
|
2025
Q1 | – | Sell |
-87,919
| Closed | -$204K | – | 5908 |
|
|
2024
Q4 | $204K | Buy |
87,919
+82,234
| +1,447% | +$191K | ﹤0.01% | 4878 |
|
|
2024
Q3 | $17.9K | Buy |
+5,685
| New | +$17.9K | ﹤0.01% | 5360 |
|
|
2024
Q2 | – | Sell |
-38,254
| Closed | -$119K | – | 5861 |
|
|
2024
Q1 | $119K | Buy |
38,254
+21,559
| +129% | +$67.3K | ﹤0.01% | 5003 |
|
|
2023
Q4 | $64.8K | Sell |
16,695
-23,880
| -59% | -$92.7K | ﹤0.01% | 5029 |
|
|
2023
Q3 | $133K | Sell |
40,575
-2,117
| -5% | -$6.92K | ﹤0.01% | 4718 |
|
|
2023
Q2 | $137K | Buy |
42,692
+31,478
| +281% | +$101K | ﹤0.01% | 4611 |
|
|
2023
Q1 | $48.2K | Sell |
11,214
-36,292
| -76% | -$156K | ﹤0.01% | 5170 |
|
|
2022
Q4 | $202K | Buy |
47,506
+27,896
| +142% | +$119K | ﹤0.01% | 4693 |
|
|
2022
Q3 | $97K | Sell |
19,610
-4,684
| -19% | -$23.2K | ﹤0.01% | 5129 |
|
|
2022
Q2 | $74K | Buy |
+24,294
| New | +$74K | ﹤0.01% | 5395 |
|
|
2022
Q1 | – | Sell |
-33,935
| Closed | -$101K | – | 6292 |
|
|
2021
Q4 | $101K | Buy |
33,935
+19,677
| +138% | +$58.6K | ﹤0.01% | 5901 |
|
|
2021
Q3 | $68K | Buy |
+14,258
| New | +$68K | ﹤0.01% | 6020 |
|
|
2021
Q2 | – | Sell |
-19,682
| Closed | -$92K | – | 6373 |
|
|
2021
Q1 | $92K | Buy |
19,682
+5,184
| +36% | +$24.2K | ﹤0.01% | 5887 |
|
|
2020
Q4 | $45K | Buy |
+14,498
| New | +$45K | ﹤0.01% | 4867 |
|